Cargando…

Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19

The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has dramatically influenced various aspects of the world. It is urgent to thoroughly study pathology and underlying mechanisms for developing effective strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xue, Zhang, Ziqi, Wang, Zhenling, Gutiérrez-Castrellón, Pedro, Shi, Huashan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189267/
https://www.ncbi.nlm.nih.gov/pubmed/35697684
http://dx.doi.org/10.1038/s41392-022-01043-6
_version_ 1784725545926262784
author Li, Xue
Zhang, Ziqi
Wang, Zhenling
Gutiérrez-Castrellón, Pedro
Shi, Huashan
author_facet Li, Xue
Zhang, Ziqi
Wang, Zhenling
Gutiérrez-Castrellón, Pedro
Shi, Huashan
author_sort Li, Xue
collection PubMed
description The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has dramatically influenced various aspects of the world. It is urgent to thoroughly study pathology and underlying mechanisms for developing effective strategies to prevent and treat this threatening disease. It is universally acknowledged that cell death and cell autophagy are essential and crucial to maintaining host homeostasis and participating in disease pathogenesis. At present, more than twenty different types of cell death have been discovered, some parts of which have been fully understood, whereas some of which need more investigation. Increasing studies have indicated that cell death and cell autophagy caused by coronavirus might play an important role in virus infection and pathogenicity. However, the knowledge of the interactions and related mechanisms of SARS-CoV-2 between cell death and cell autophagy lacks systematic elucidation. Therefore, in this review, we comprehensively delineate how SARS-CoV-2 manipulates diverse cell death (including apoptosis, necroptosis, pyroptosis, ferroptosis, and NETosis) and cell autophagy for itself benefits, which is simultaneously involved in the occurrence and progression of COVID-19, aiming to provide a reasonable basis for the existing interventions and further development of novel therapies.
format Online
Article
Text
id pubmed-9189267
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91892672022-06-15 Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19 Li, Xue Zhang, Ziqi Wang, Zhenling Gutiérrez-Castrellón, Pedro Shi, Huashan Signal Transduct Target Ther Review Article The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has dramatically influenced various aspects of the world. It is urgent to thoroughly study pathology and underlying mechanisms for developing effective strategies to prevent and treat this threatening disease. It is universally acknowledged that cell death and cell autophagy are essential and crucial to maintaining host homeostasis and participating in disease pathogenesis. At present, more than twenty different types of cell death have been discovered, some parts of which have been fully understood, whereas some of which need more investigation. Increasing studies have indicated that cell death and cell autophagy caused by coronavirus might play an important role in virus infection and pathogenicity. However, the knowledge of the interactions and related mechanisms of SARS-CoV-2 between cell death and cell autophagy lacks systematic elucidation. Therefore, in this review, we comprehensively delineate how SARS-CoV-2 manipulates diverse cell death (including apoptosis, necroptosis, pyroptosis, ferroptosis, and NETosis) and cell autophagy for itself benefits, which is simultaneously involved in the occurrence and progression of COVID-19, aiming to provide a reasonable basis for the existing interventions and further development of novel therapies. Nature Publishing Group UK 2022-06-13 /pmc/articles/PMC9189267/ /pubmed/35697684 http://dx.doi.org/10.1038/s41392-022-01043-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Li, Xue
Zhang, Ziqi
Wang, Zhenling
Gutiérrez-Castrellón, Pedro
Shi, Huashan
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
title Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
title_full Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
title_fullStr Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
title_full_unstemmed Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
title_short Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
title_sort cell deaths: involvement in the pathogenesis and intervention therapy of covid-19
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189267/
https://www.ncbi.nlm.nih.gov/pubmed/35697684
http://dx.doi.org/10.1038/s41392-022-01043-6
work_keys_str_mv AT lixue celldeathsinvolvementinthepathogenesisandinterventiontherapyofcovid19
AT zhangziqi celldeathsinvolvementinthepathogenesisandinterventiontherapyofcovid19
AT wangzhenling celldeathsinvolvementinthepathogenesisandinterventiontherapyofcovid19
AT gutierrezcastrellonpedro celldeathsinvolvementinthepathogenesisandinterventiontherapyofcovid19
AT shihuashan celldeathsinvolvementinthepathogenesisandinterventiontherapyofcovid19